Adiposity and cancer risk: new mechanistic insights from epidemiology
Open accessThe DOI matches its Crossref record; 174 of the 174 references it cites were found in a registry or an index.
Abstract
Excess body adiposity, commonly expressed as body mass index (BMI), is a risk factor for many common adult cancers. Over the past decade, epidemiological data have shown that adiposity-cancer risk associations are specific for gender, site, geographical population, histological subtype and molecular phenotype. The biological mechanisms underpinning these associations are incompletely understood but need to take account of the specificities observed in epidemiology to better inform future prevention strategies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Systematic reviews on insulin-like growth factor or adiposity and cancer risk took laboratory, animal, and human evidence into account to judge the plausibility of different mechanisms [40,101].”
From COSMOS-E: Guidance on conducting systematic reviews and meta-analyses of observational studies of etiology (2019) · cites this paper as [101]
In the citing paper
“based on epidemiological and other evidence, obesity probably increases the risk of several cancers [101,103]”
From COSMOS-E: Guidance on conducting systematic reviews and meta-analyses of observational studies of etiology (2019) · cites this paper as [101]
In the citing paper
“Epidemiology studies have provided evidence for an association between obesity-related metabolic and inflammatory factors, including changes in insulin-like growth factor 1 signaling, adipokines, sex hormones, and systemic inflammation, and CRC risk.80”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [80]
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Genetics of Food Intake Self-Regulation in Childhood: Literature Review and Research Opportunities
Faith, M. S., Carnell, S., & Kral, T. V. E. (2013) · Human Heredity · doi:10.1159/000353879 · Cited by 7,601
Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60269-x · Cited by 5,219
Self-citationAdipokines in inflammation and metabolic disease
Ouchi, N., Parker, J. L., Lugus, J. J., & Walsh, K. (2011) · Nature Reviews Immunology · doi:10.1038/nri2921 · Cited by 4,625
Functional interactions between the gut microbiota and host metabolism
Tremaroli, V., & Bäckhed, F. (2012) · Nature · doi:10.1038/nature11552 · Cited by 4,387
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613
European Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Kim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Cited by
Items 301–400 of 678
Gómez, D., Jiménez‐Fonseca, P., Manzano, A., Castellanos, P. C., Arbizu, M. V., Cabañes, R. M., Lorente, D., Ferreira, E., del Río, J., García, T., et al. (2021) · The Oncologist · doi:10.1002/onco.13687 · Cited by 18
“There is a causal relation between excessive adiposity and the risk of developing cancer [9].”
BackgroundIncreased prevalence of obstructive sleep apnea in women diagnosed with endometrial or breast cancer
Madut, A., Fuchsova, V., Man, H., Askar, S., Trivedi, R., Elder, E., Clarke, C. L., Wain, G., Brand, A. H., DeFazio, A., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0249099 · Cited by 19
“This lack of information is particularly problematic given obesity is a known major risk factor for both OSA and a number of cancers in women, in particular, endometrial cancer and postmenopausal breast cancer [7].”
BackgroundObesity and endometrial cancer: unanswered epidemiological questions
Renehan, A. G., MacKintosh, M. L., & Crosbie, E. J. (2015) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.13731 · Cited by 18
Self-citationde Cedrón, M. G., Mouhid, L., García-Carrascosa, E., Fornari, T., Reglero, G., & de Molina, A. R. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00455 · Cited by 19
“A key event during tumorigenesis is the reprogramming of the cancer energetic metabolism (Hanahan and Weinberg, 2011), and obesityassociated alterations (hormones, growth factors, cytokines, and other inflammatory molecules) may promote protumoral signals in pre- or neoplastic cells by interacting through their recept…”
BackgroundBuechel, M. E., Enserro, D., Burger, R. A., Brady, M. F., Wade, K., Secord, A. A., Nixon, A. B., Mirniaharikandehei, S., Liu, H., Zheng, B., et al. (2021) · Gynecologic Oncology · doi:10.1016/j.ygyno.2021.02.032 · Cited by 17
Body mass index-associated molecular characteristics involved in tumor immune and metabolic pathways
Hu, C., Chen, X., Yao, C., Liu, Y., Xu, H., Zhou, G., Xia, H., & Xia, J. (2020) · Cancer & Metabolism · doi:10.1186/s40170-020-00225-6 · Cited by 18
“Adipose tissue affects the synthesis and bioavailability of sex hormones and mediates the association between excess body weight and hormone-related cancers [13, 16].”
BackgroundNew therapeutic targets for endometrial cancer: a glimpse into the preclinical sphere
Bruchim, I., Capasso, I., Polonsky, A., Meisel, S., Salutari, V., Werner, H., Lorusso, D., Scambia, G., & Fanfani, F. (2024) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2024.2316739 · Cited by 18
The SARIFA biomarker in the context of basic research of lipid-driven cancers
Märkl, B., Reitsam, N. G., Grochowski, P., Waidhauser, J., & Grosser, B. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00662-2 · Cited by 18
“The fact that obese people are more frequently affected by cancer and have a more aggressive clinical course compared to lean people is the primary motivation for this intensive research 12,13 .”
Moodi, M., Tavakoli, T., & Tahergorabi, Z. (2021) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_266_20 · Cited by 17
“Obesity is associated with nonalcoholic fatty liver disease (NAFLD), including simple steatosis, nonalcoholic steatohepatitis (NASH), fibrosis and cirrhosis that NASH in turn is risk factors for liver fibrosis and development of HCC.[80,81] NAFLD and NASH are considered as risk factors for GI cancers, particularly col…”
BackgroundHjortebjerg, R., Bojsen-Møller, K. N., Søeby, M., Oxvig, C., Madsbad, S., & Frystyk, J. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154886 · Cited by 17
The role of bone marrow adipocytes in cancer progression: the impact of obesity
Hernandez, M., Shin, S., Muller, C., & Attané, C. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10042-6 · Cited by 18
“in 2003 [8], it has been recognized that excess body weight increases cancer occurrence and worsens prognosis; however, this depends on cancer type [9].”
BackgroundAssociations between Body Mass Index and Prostate Cancer: The Impact on Progression-Free Survival
Popovici, D. I., Stanisav, C., Pricop, M. O., Dragomir, R., Săftescu, S., & Ciurescu, D. (2023) · Medicina · doi:10.3390/medicina59020289 · Cited by 17
“Obese people suffer from significant metabolic and endocrinological abnormalities that lead to enhanced insulin and insulin-growth factor signaling, dysregulation of sex hormone metabolism, and adipose tissue-derived inflammation [2,5].”
BackgroundSedentary Behaviour and Cancer
Lynch, B. M., Mahmood, S., & Boyle, T. (2017) · Springer series on epidemiology and public health · doi:10.1007/978-3-319-61552-3_10 · Cited by 17
Wang, T., Moon, J., Wu, Y., Amos, C. I., Hung, R. J., Tardón, A., Andrew, A. S., Chen, C., Christiani, D. C., Albanes, D., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185660 · Cited by 20
Nguyen, N. T. H., Nguyen, P., Huang, C., Wang, C., Lin, M., Hsu, M., Hoang, B. B., Chien, S.-C., & Yang, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043814 · Cited by 16
Davey, M. G., Ryan, O. K., Ryan, É. J., Donlon, N. E., Reynolds, I. S., Fearon, N. M., Martin, S., & Heneghan, H. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06674-4 · Cited by 17
“While data from Memorial Sloan Kettering and MD Anderson Cancer Centre illustrate no compromise in shortterm surgical outcomes following CRC resection [61, 62], the data illustrating the contributary role of obesity to CRC development is irrefutable [10-12].”
BackgroundGuanylyl Cyclase C Hormone Axis at the Intersection of Obesity and Colorectal Cancer
Blomain, E. S., Merlino, D. J., Pattison, A. M., Snook, A. E., & Waldman, S. A. (2016) · Molecular Pharmacology · doi:10.1124/mol.115.103192 · Cited by 17
“Potential mechanisms linking obesity and colorectal cancer risk traditionally have included endocrine, adipokine, and inflammatory changes associated with the adipose mass (Renehan et al., 2015).”
BackgroundWade, K. H., Carslake, D., Tynelius, P., Smith, G. D., & Martin, R. M. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1002868 · Cited by 17
Gillen, J. M., Mills, K. A., Dvořák, J., Zheng, B., Thai, T., Salani, R., Cosgrove, C. M., Davidson, B. A., Thaker, P. H., & Moore, K. N. (2019) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2019.100502 · Cited by 17
“Increasing weight and obesity is associated with the development of endometrial cancer through increased aromatization of androgens in peripheral fat cells, chronic hyperinsulinemia and subsequent reduction in circulating sex hormone binding globulin, and promotion of a pro-inflammatory state (Renehan et al., 2015).”
BackgroundBuckley, E. S., Mullen, M. M., Nizamuddin, R., Stein, J. H., Kuroki, L. M., Fuh, K. C., Hagemann, A. R., McCourt, C. K., Mutch, D., Khabele, D., et al. (2022) · Gynecologic Oncology · doi:10.1016/j.ygyno.2022.09.011 · Cited by 16
COVID-19 and liver injury in individuals with obesity
Lempesis, I. G., Karlafti, E., Papalexis, P., Fotakopoulos, G., Tarantinos, K., Lekakis, V., Papadakos, S. P., Cholongitas, Ε., & Georgakopoulou, V. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i6.908 · Cited by 16
Measuring body composition and regional fat mass accurately
Denton, N., & Karpe, F. (2016) · Practical Diabetes · doi:10.1002/pdi.2043 · Cited by 20
Schwartz, S. S., Grant, S. F. A., & Herman, M. E. (2019) · Postgraduate Medicine · doi:10.1080/00325481.2019.1657358 · Cited by 16
“These changes have been found to occur proportional to BMI [24,25].”
BackgroundAteiwi, Y. A., Mahmood, R. R., Wong, H. J., Low, C. E., Yau, C. E., Lee, A. R. Y. B., Eng, P. C., Lee, M., Chan, M. Y., & Sia, C. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113158 · Cited by 17
Anthropometric traits and risk of multiple myeloma: a pooled prospective analysis
Bertrand, K. A., Teras, L. R., Deubler, E. L., Chao, C., ROSNER, B. A., Wang, K., Zhong, C., Wang, S., & Birmann, B. M. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01907-2 · Cited by 18
“Obesity is also linked to heightened inflammation, deregulation of endogenous hormonal pathways that can influence cell-cycle control, insulin resistance and immune dysfunction [30, 47].”
BackgroundFortner, R. T., Brantley, K. D., Tworoger, S. S., Tamimi, R. M., ROSNER, B. A., Holmes, M. D., Willett, W. C., & Eliassen, A. H. (2024) · Breast Cancer Research and Treatment · doi:10.1007/s10549-023-07238-x · Cited by 19
“The associations between adiposity [21, 22] and physical activity [23, 24] and these mechanisms have been described previously with lower levels of adiposity and higher levels of physical activity, for example, associated with lower circulating estradiol, improvements in insulin resistance, and…”
BackgroundWang, K.-X., Shi, D.-M., Shi, X., Wang, J., & Ai, X. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1533464 · Cited by 16
Arnold, M., Renehan, A. G., & Colditz, G. A. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0940 · Cited by 15
“related to a vast array of metabolic and physiological dysfunctions, underlying biological mechanisms have been identified explaining many of these associations (6).”
BackgroundSelf-citationWard, H. A., Wark, P. A., Muller, D. C., Steffen, A., Johansson, M., Norat, T., Gunter, M. J., Overvad, K., Dahm, C. C., Halkjær, J., et al. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0886 · Cited by 16
“Proposed mechanisms for adiposity-cancer associations include insulin and insulin-like growth factors, sex steroids, adipokines, and systematic inflammation (39).”
Malpique, R., Sánchez‐Infantes, D., García-Beltrán, C., Taxerås, S. D., López‐Bermejo, A., de Zegher, F., & Ibáñez, L. (2019) · Pediatric Obesity · doi:10.1111/ijpo.12500 · Cited by 15
“These findings may be relevant in view of the evidence that young women with PCOS are at high risk (up to 18‐fold) for developing endometrial carcinoma,(16) which happens to be the most BMI dependent among human cancers.(17,18) If future studies indicate that chronic hepato‐ visceral adiposity and prolonged elevation…”
BackgroundVisceral fat percentage for prediction of outcome in uterine cervical cancer
Eide, A. J., Halle, M. K., Lura, N. G., Fasmer, K. E., Wagner-Larsen, K. S., Forsse, D., Bertelsen, B. I., Salvesen, Ø. O., Krakstad, C., & Haldorsen, I. S. (2023) · Gynecologic Oncology · doi:10.1016/j.ygyno.2023.06.581 · Cited by 17
Cha, J.-Y., Park, J., Hong, Y.-K., Jeun, S., & Ahn, S. (2021) · Integrative Cancer Therapies · doi:10.1177/1534735421991233 · Cited by 15
“The exclusion criteria were: (1) proven Isocitrate dehydrogenase (IDH) mutation, and/or 1p19q codeletion and (2) patients younger than 20 years.”
BackgroundViolette, C. J., Agarwal, R., Mandelbaum, R. S., González, J. L., Hong, K. M., Roman, L. D., Klar, M., Wright, J. D., Paulson, R. J., Obermair, A., et al. (2023) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2023.2194636 · Cited by 15
“and exacerbate insulin resistance, in addition to contributing to endometrial proliferation [20,21].”
BackgroundBreast cancers as ecosystems: a metabolic perspective
Martino, F., Lupi, M., Giraudo, E., & Lanzetti, L. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04902-9 · Cited by 18
“This latter evidence, however, confronts us with a substantial paradox: why is the ER + BC risk increasing with obesity after menopause, but not before, considering that there is abundance of circulating estrogens before menopause? In actual fact, the situation is even more complex, since pre-menopausal obese women ma…”
BackgroundLi, J., Chen, X. L., Shaker, A., Oshima, T., Shan, J., Miwa, H., Feng, C., & Zhang, J. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13157 · Cited by 14
Mauland, K. K., Ju, Z., Tangen, I. L., Berg, A., Kalland, K.-H., Oyan, A. M., Bjørge, L., Westin, S. N., Krakstad, C., Trovik, J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22203 · Cited by 14
“So far, excess body weight is thought to influence endometrial cancer development through at least three different mechanisms; excess estrogen levels, insulin mediated effects, and secretion of pro-inflammatory mediators from the adipose tissue [7–10].”
Overweight and obesity do not determine worst prognosis in endometrioid endometrial carcinoma
Chaves, G. V., Simão, T. D. A., Pinto, L. F. R., Moreira, M. Â. M., Bergmann, A. K., & Chaves, C. B. P. (2019) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-019-05281-y · Cited by 14
Wang, Y., Newton, C. C., McCullough, M. L., Teras, L. R., Bodelón, C., Rees‐Punia, E., Um, C. Y., Makaroff, L. A., & Patel, A. V. (2025) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaf051 · Cited by 14
Garg, T. K., Young, A. J., O'Keeffe-Rosetti, M. C., McMullen, C. K., Nielsen, M. E., Murphy, T. E., & Kirchner, H. L. (2020) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2020.04.010 · Cited by 13
Skeletal muscle is prognostic in resected stage III malignant melanoma
Youn, S., Eurich, D. T., McCall, M., Walker, J. W. T., Smylie, M., & Sawyer, M. B. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.03.001 · Cited by 13
Timmins, I. R., Jones, M. E., O’Brien, K. M., Adami, H., Aune, D., Baglietto, L., Bertrand, K. A., Brantley, K. D., Chen, Y., DeHart, J. C., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.23.01101 · Cited by 16
“52 Higher insulin levels may also reduce sex hormone – binding globulin levels and thereby increase bioavailability of estrogens and androgens, 53 suggesting another possible mechanism.”
BackgroundLung Cancer, Smoking, and Obesity: It’s Complicated
Samet, J. M. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy019 · Cited by 13
Schübel, R., Sookthai, D., Greimel, J., Johnson, T., Grafetstätter, M., Kirsten, R., Kratz, M., Ulrich, C. M., Kaaks, R., & Kuhn, T. E. (2019) · Nutrients · doi:10.3390/nu11030639 · Cited by 13
de Carvalho, C. S., Silva, T. H., André, J. C. S., de Barros, L. A. S., Ferreira, A. A., Murad, L. B., & Peres, W. A. F. (2020) · Nutrition in Clinical Practice · doi:10.1002/ncp.10624 · Cited by 13
The Unique Microbiome and Immunity in Pancreatic Cancer
Wei, X., Mei, C., Li, X., & Xie, Y. (2021) · Pancreas · doi:10.1097/mpa.0000000000001744 · Cited by 14
“Numerous studies have confirmed that obesity increases the risk of cancers, including PDAC.(101) High-fat diet also can accelerate PDAC formation in mouse models.”
BackgroundBergqvist, M., Elebro, K., Borgquist, S., & Rosendahl, A. H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.628653 · Cited by 13
Lipid Intake and Breast Cancer Risk: Is There a Link? A New Focus and Meta-Analysis
Lodi, M., Kiehl, A., Qu, F., Gabriele, V., Tomasetto, C., & Mathelin, C. (2022) · European Journal of Breast Health · doi:10.4274/ejbh.galenos.2021.2021-11-2 · Cited by 16
“Adiponectin has an anti-inflammatory and antineoplastic action (66).”
BackgroundAlshamsan, B., Suleman, K., Agha, N., Abdelgawad, M., Alzahrani, M. J., Elhassan, T. A. M., Al‐Tweigeri, T., Ajarim, D. S., & Alsayed, A. (2022) · International Journal of Women s Health · doi:10.2147/ijwh.s343558 · Cited by 16
The Cancer Research UK - Ludwig Cancer Research Nutrition and Cancer Prevention Collaborative Group (2019) · BMC Medicine · doi:10.1186/s12916-019-1383-9 · Cited by 17
Anari, M., Karimkhanloo, H., Nie, S., Li, D., Fidelito, G., Bayliss, J. A., Keenan, S. N., Slavin, J., Lin, S., Cheng, Z., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.115007 · Cited by 14
Bea, J. W., Ochs‐Balcom, H. M., Valencia, C. I., Chen, Z., Blew, R. M., Lind, K. E., Caan, B. J., Roe, D. J., Rohan, T. E., Reeves, K. W., et al. (2025) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkaf007 · Cited by 12
Periprostatic Adipose Tissue as a Contributor to Prostate Cancer Pathogenesis: A Narrative Review
Drewa, J., Lazar-Juszczak, K., Adamowicz, J., & Juszczak, K. (2025) · Cancers · doi:10.3390/cancers17030372 · Cited by 18
“Additionally, Renehan et al. [20] proposed several hormonal pathomechanisms attributed to cancer development, as follow: (1) adipokine-related pathways, (2) altered sex hormone metabolism, and (3) elevated insulin level and increased bioavailability of insulin-like growth factor 1 (IGF-1).”
Feng, X., Li, R., Yi, H., Chen, S., Liu, M., & Wu, Y. (2025) · Obesity · doi:10.1002/oby.24219 · Cited by 12
“Many studies have proposed various mechanisms to explain how EBW leads to an increased risk of cancer, with chronic inflammation and hormonal system alterations being the most common hypotheses [38].”
Vitamin D: What role in obesity-related cancer?
Martinez, P., & Grant, W. B. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.03.007 · Cited by 13
Schembre, S. M., Jospe, M. R., Bedrick, E. J., Li, L., Brewster, A. M., Levy, E. J., Dirba, D. D., Campbell, M., Taylor, R. W., & Basen‐Engquist, K. (2022) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-21-0298 · Cited by 12
Højman, P., Stagaard, R., Adachi-Fernandez, E., Deshmukh, A. S., Mund, A., Olsen, C. H., Keller, L., Pedersen, B. K., & Gehl, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-08850-5 · Cited by 14
Playdon, M. C., Hardikar, S. S., Karra, P., Hoobler, R., Ibele, A. R., Cook, K. L., Kumar, A., Ippolito, J. E., & Brown, J. C. (2023) · JNCI Monographs · doi:10.1093/jncimonographs/lgad003 · Cited by 14
Liao, J., Goodrich, J. A., Chen, W., Qiu, C., Chen, J. C., Costello, E. J., Alderete, T. L., Chatzi, L., Gilliland, F. D., & Chen, Z. (2024) · Scientific Reports · doi:10.1038/s41598-024-57751-2 · Cited by 13
Rios, J. L., Ko, L., Joumaa, V., Liu, S., Diefenthaeler, F., Sawatsky, A., Hart, D. A., Reimer, R. A., & Herzog, W. (2019) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2019.03.031 · Cited by 12
Breast Cancer: A Review of Mammography and Clinical Breast Examination for Early Detection of Cancer
Balali, G. I., Yar, D. D., Gobe, V. A. D., Effah-Yeboah, E., Asumang, P., Akoto, J. D., & Abdallah, F. (2020) · OALib · doi:10.4236/oalib.1106866 · Cited by 20
“Although the exact mechanisms by which obesity increases the risk of cancers is not yet known, the interaction of the adipose tissue with the oestrogen hormone could initiate tumour growth and progression [32].”
BackgroundThe role of sarcopenic obesity in high‐grade endometrial cancer
Donkers, H., Fasmer, K. E., McGrane, J., Pijnenborg, J. M. A., Bekkers, R. L. M., Haldorsen, I. S., & Galaal, K. A. (2021) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13591 · Cited by 12
Metabolically healthy overweight/obesity and cancer risk: A representative cohort study in Taiwan
Lin, C.-J., Chang, Y., Hsu, H., Tsai, M.-C., Hsu, L., Hwang, L., Chien, K., & Yeh, T. (2021) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2021.10.004 · Cited by 12
Recalde, M., Pistillo, A., Viallon, V., Fontvieille, E., Duarte‐Salles, T., & Freisling, H. (2022) · Cancer Medicine · doi:10.1002/cam4.6603 · Cited by 12
“7,28,29 However, since the “ healthy” population did not include individuals with HTN , T2DM , and CVD by definition, our results support the existence of pathways between body fatness and cancer risk independent of these conditions.”
ResultAdvances in biomedical applications of vitamin D for VDR targeted management of obesity and cancer
Gupta, V. K., Sahu, L., Sonwal, S., Suneetha, A., Kim, D. H., Kim, J., Verma, H. K., Pavitra, E., Raju, G. S. R., Bhaskar, L. V., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117001 · Cited by 11
Sun, M., Häggström, C., da Silva, M., Mboya, I. B., Lagerros, Y. T., Michaëlsson, K., Sandin, S., Leppert, J., Hägg, S., Elmståhl, S., et al. (2025) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaf075 · Cited by 11
“10,33,34 The strengths of our study include the large sample size, long follow-up, and detailed cancer categorization.”
High-dimensional immunotyping of tumors grown in obese and non-obese mice
Wogsland, C. E., Lien, H. E., Pedersen, L., Hanjra, P., Grøndal, S. M., Brekken, R. A., Lorens, J. B., & Halberg, N. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.048977 · Cited by 11
“INTRODUCTION Obesity is a risk factor for at least 13 types of cancer including breast and pancreatic cancer (Genkinger et al., 2011; Pierobon and Frankenfeld, 2013; Renehan et al., 2015; Picon-Ruiz et al., 2017).”
BackgroundKang, N., Li, Z., Liu, H., Tian, X., Wang, J., Wu, Y., Xiong, L., Zou, X., Peng, Y., Zhou, Z., et al. (2022) · Nutrients · doi:10.3390/nu14163388 · Cited by 12
“Many plausible biological mechanisms such as insulin resistance, insulin-like growth factors, and sex hormones pathways have explained how obesity leads to RCC [41,42].”
BackgroundZapater‐Moros, A., Díaz-Beltrán, L., Gámez‐Pozo, A., Trilla‐Fuertes, L., Lumbreras-Herrera, M. I., López‐Camacho, E., González‐Olmedo, C., Espinosa, E., Zamora, P. M., Sánchez‐Rovira, P., et al. (2023) · Metabolomics · doi:10.1007/s11306-023-02024-8 · Cited by 11
“Both mechanisms, in turn, are associated with the development of breast cancer (Renehan et al., 2015).”
BackgroundImpact of body mass index on survival outcome in patients with differentiated thyroid cancer
Al‐Ammar, Y., Al‐Mansour, B., Al‐Rashood, O., Tunio, M. A., Islam, T., AlAsiri, M., & Al-Qahtani, K. H. (2017) · Brazilian Journal of Otorhinolaryngology · doi:10.1016/j.bjorl.2017.02.002 · Cited by 11
“Tipo de cirurgia Tireoidectomia parcial ou total 189 (90,4) Lobectomia 20 (9,6)”
InfluentialShi, D., Ao, L., Yu, H., Li, J., Xia, Y., Wu, X., He, D., Zhong, W., & Xia, H. (2021) · Cancer Epidemiology · doi:10.1016/j.canep.2021.101946 · Cited by 11
Li, H., Yao, Q., Li, C., Fan, L., Wu, H., Zheng, N., & Wang, J. (2022) · Foods · doi:10.3390/foods11243956 · Cited by 11
“In adipose tissue, excessive leptin levels activate the PI3K–MAPK signaling pathways, inhibiting apoptosis while enhancing angiogenesis and mitogenesis in colon tumor cells [11].”
BackgroundErtaylan, G., Cornet, C. L., van Roekel, E. H., Jung, A. Y., Bours, M. J. L., Damms-Machado, A., van den Brandt, P. A., Schöck, H., de Kok, T. M. C. M., Theys, J., et al. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-0230 · Cited by 11
“During stage II, a systematic literature review was conducted of the mechanistic literature on one specific IP, namely the insulin-like growth factor 1 receptor (IGF1R) as part of the proposed insulin-IGF hypothesis (7), in linking body fatness to breast cancer.”
BackgroundCardiometabolic profile of women with uterine leiomyoma: a cross-sectional study
AlAshqar, A., Ouweini, H. E., Gornet, M. E., Yenokyan, G., & Borahay, M. A. (2022) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.22.04952-1 · Cited by 14
Santo, V., Brunetti, L., Pecci, F., Peroni, M., Barnini, G., Paoloni, F., Buti, S., Tiseo, M., Ricciuti, B., Pinato, D. J., et al. (2025) · Current Oncology Reports · doi:10.1007/s11912-025-01718-7 · Cited by 15
“Nevertheless, historical epidemiological data report an inverse association between the body mass index (BMI) and lung cancer risk, likely due to residual confounding influence of smoking [ 10 ].”
Ovarian, Uterine, and Vulvovaginal Cancers
Kwolek, D. S., Gerstberger, S. C., Tait, S. D., & Qiu, J. M. (2023) · Medical Clinics of North America · doi:10.1016/j.mcna.2022.10.016 · Cited by 11
Deng, Z., Hajihosseini, M., Moore, J. X., Khan, S., Graff, R. E., Bondy, M. L., Chung, B. I., & Langston, M. E. (2023) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-23-0668 · Cited by 13
Guo, S., Zhao, Y., Jiang, Y., Ye, H., & Wang, Y. (2023) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2023.12.018 · Cited by 12
The Impact of High Adiposity on Endometrial Progesterone Response and Metallothionein Regulation
Murphy, A. R., Asif, H., Cingoz, H., Gourronc, F. A., Ankrum, J. A., Klingelhutz, A. J., & Kim, J. J. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae236 · Cited by 10
Fortner, R. T., Hüsing, A., Dossus, L., Tjønneland, A. M., Overvad, K., Dahm, C. C., Arveux, P., Fournier, A., Kvaskoff, M., Schulze, M. B., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.32901 · Cited by 10
“, high body mass index [BMI]).(4) Finally, long-term use of oral contraceptives (OC) is associated with marked reductions in EC risk, which persist for years after cessation of use,(5) and smoking has also been associated with lower risk.”
BackgroundVaidya, R., Till, C., Greenlee, H., Hershman, D. L., & Unger, J. M. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.34445 · Cited by 11
Shaw, K. A., Zello, G. A., & Crizzle, A. M. (2023) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000002968 · Cited by 11
“31 These hormonal responses may also explain why a significant association was observed when WC was used alongside BMI, but not for BMI alone.”
BackgroundKu, S.-C., Ho, P., Tseng, Y., Yeh, T., Cheng, S.-L., & Liang, C. (2018) · Psychiatry Investigation · doi:10.30773/pi.2018.05.02.1 · Cited by 10
Extrahepatic Malignancies in Nonalcoholic Fatty Liver Disease
Ahmed, O. T., & Allen, A. M. (2019) · Current Hepatology Reports · doi:10.1007/s11901-019-00499-5 · Cited by 10
Trajectories of body mass index in adulthood and risk of subtypes of postmenopausal breast cancer
Busund, M., Ursin, G., Lund, E., Wilsgaard, T., & Rylander, C. (2023) · Breast Cancer Research · doi:10.1186/s13058-023-01729-x · Cited by 10
“Other potential contributing mechanisms include altered insulin and insulin-like growth factor-I levels and chronic low-grade inflammation [65].”
BackgroundTakaoka, S., Hamada, T., Takahara, N., Fukuda, R., Hakuta, R., Ishigaki, K., Kanai, S., Kurihara, K., Matsui, H., Michihata, N., et al. (2024) · Journal of Gastroenterology · doi:10.1007/s00535-024-02124-9 · Cited by 9
Macis, D., Bellerba, F., Aristarco, V., Johansson, H. A., Guerrieri‐Gonzaga, A., Lazzeroni, M., Šestak, I., Cuzick, J. M., DeCensi, A., Bonanni, B., et al. (2024) · Nutrients · doi:10.3390/nu16132098 · Cited by 11
“Furthermore, there is yet only indirect evidence that reversing excess weight reduces cancer incidence, and this effect may not be visible for up to ten years [10].”
BackgroundDistinct Effects of Adipose-Derived Stem Cells and Adipocytes on Normal and Cancer Cell Hierarchy
Anjanappa, M., Burnett, R. M., Zieger, M. A. J., Merfeld‐Clauss, S., Wooden, W. A., March, K. L., Tholpady, S. S., & Nakshatri, H. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0055 · Cited by 9
“Nonetheless, it is important to investigate the effects of ASCs and adipocytes on cancer cells because of the established link between obesity and cancer (4).”
BackgroundInfluentialLindstad, T., Qu, S., Sikkeland, J., Jin, Y., Kristian, A., Mælandsmo, G. M., Collas, P., & Saatcioglu, F. (2016) · Oncotarget · doi:10.18632/oncotarget.11131 · Cited by 9
“com/oncotarget of sex hormones and adipokines, and inflammation (for reviews, see [13, 51]).”
BackgroundCancer risk in people living with HIV
Hessol, N. A., & Strickler, H. D. (2017) · The Lancet HIV · doi:10.1016/s2352-3018(17)30147-9 · Cited by 9
Ose, J., Holowatyj, A. N., Nattenmüller, J., Gigic, B., Lin, T., Himbert, C., Habermann, N., Achaintre, D., Scalbert, A., Keski‐Rahkonen, P., et al. (2020) · Cancer Causes & Control · doi:10.1007/s10552-020-01312-1 · Cited by 9
Rothschild, H., Abel, M. K., Patterson, A. K., Goodman, K., Shui, A. M., Baelen, K. V., Desmedt, C., Benz, C. C., & Mukhtar, R. A. (2021) · Breast Cancer Research and Treatment · doi:10.1007/s10549-021-06453-8 · Cited by 9
Computational approaches to predicting treatment response to obesity using neuroimaging
Kozarzewski, L., Maurer, L., Mähler, A., Spranger, J., & Weygandt, M. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09701-w · Cited by 10
Wang, W., Qiao, L., Dong, W., Ren, J. L., Chang, X., Zhan, S., Du, P., Xi, Y., & Wang, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.798829 · Cited by 9
“One potential explanation for this phenomenon is that metabolically unhealthy individuals had the propensity to develop more local ectopic fat, which contributes to systematic inflammation and serves as a favorable environment for tumor development (31).”
BackgroundThe impact of obesity and lipids on cancer: Insights into mechanisms and potential interventions
Romero, M., Lian, Y., Piquer, A., Borràs-Ferré, N., Zorzano, A., & Ivanova, S. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.07.006 · Cited by 8
Obesity as a Systems‐Level Driver of Cancer: Mechanisms and Nutritional Reprogramming
Munteanu, C., & Dhanasekaran, D. N. (2025) · Obesity Reviews · doi:10.1111/obr.70075 · Cited by 9
Hawwash, N. K., Sperrin, M., Martin, G. P., Sinha, R., Matthews, C. E., Ricceri, F., Tjønneland, A. M., Heath, A. K., Neuhouser, M. L., Joshu, C. E., et al. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102921 · Cited by 9
“42 Cumulative adiposity exposure could have posed a greater risk of insulin resistance which is a plausible biological explanation for the increased risk of cancer.”
Self-citationLife course evolution of body size and breast cancer survival in the E3N cohort
His, M., Guélennec, M. L., Mesrine, S., Boutron‐Ruault, M., Clavel‐Chapelon, F., Fagherazzi, G., & Dossus, L. (2017) · International Journal of Cancer · doi:10.1002/ijc.31177 · Cited by 8
“The associations between the “moderate increase” in body size and “constantly high” trajectories and lower breast cancer survival may be related to the systemic inflammation associated with weight gain(31) and excess adiposity.(32) Indeed, together with pathways involving growth factors and insulin resistance, inflamm…”
BackgroundAduse‐Poku, L., Bian, J., Gopireddy, D. R., Hernandez, M., Lall, C. G., Falzarano, S. M., Masood, S., Jo, A., & Cheng, T. D. (2022) · Cancers · doi:10.3390/cancers14071846 · Cited by 8
“Optimal measurement of adipose tissue would require both the amount and sites of disposition of the adipose tissue [26].”
BackgroundMazumder, H., Husain, M., Hossain, M. F., & Mahmud, S. A. S. (2023) · PLoS ONE · doi:10.1371/journal.pone.0290994 · Cited by 8
“Excess body fat can lead to ORC by causing changes in the body such as chronic inflammation and hormonal imbalance, and altering microbiome composition [5].”
BackgroundRole of Obesity in Human Health and Disease
Rao, V., & Rao, L. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.90990 · Cited by 9
Metadata
- Authors
- Renehan, A. G., Zwahlen, M., & Egger, M.
- Affiliations
- Manchester Academic Health Science Centre (GB)
- University of Bern (CH)
- Corresponding author
- Renehan, Andrew G.
- Venue
- Nature Reviews Cancer
- Published
- 2015-07-24
- Volume
- 15
- Issue
- 8
- Pages
- 484-498
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1685808974
- Cited by
- 654
- References
- 173
- Citations by year
- 2026: 40 · 2025: 57 · 2024: 71 · 2023: 64 · 2022: 55 · 2021: 69 · 2020: 54 · 2019: 58 · 2018: 54 · 2017: 68 · 2016: 56 · 2015: 7
- FWCI
- 6.55
- Type
- journal article
- Language
- en
- Open access
- green
- boris.unibe.ch
- Licence
- cc-by-nc
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Bern Open Repository and Information System (University of Bern) (submittedVersion, cc-by-nc)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- American Institute for Cancer Research
- Cancer Research UK
- Medical Research Council (MR/K006665/1, MC_PC_13042)
- Economic and Social Research Council (ES/F029721/1, ES/J010014/1)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- obesity, adiposity, cancer risk, body mass index, sex differences, tumor location, histological subtypes, molecular phenotypes, biological mechanisms, cancer prevention
- MeSH terms
- Animals, Humans, Inflammation, Neoplasms, Obesity, Risk Factors, Body Mass Index, Incidence, Adiposity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.